Novavax to Present at the 14th Annual Needham Healthcare Conference
April 08 2015 - 4:01PM
Novavax, Inc., (Nasdaq:NVAX) a clinical-stage vaccine company
focused on the discovery, development and commercialization of
recombinant nanoparticle vaccines and adjuvants, today announced
Stanley C. Erck, President and Chief Executive Officer, will
present at the 14th Annual Needham Healthcare Conference at 8:00
a.m. ET, April 15, 2015 in New York City at the Westin Grand
Central Hotel.
A live webcast link for the presentation will be available via
the company website at www.novavax.com under Investor
Info/Events.
About Novavax
Novavax, Inc. (Nasdaq:NVAX) is a clinical-stage vaccine company
committed to delivering novel products to prevent a broad range of
infectious diseases. Its recombinant nanoparticles and Matrix-M™
adjuvant technology are the foundation for ground-breaking
innovation that improves global health through safe and effective
vaccines. Additional information about Novavax is available on the
company's website, www.novavax.com.
CONTACT: Novavax, Inc.
Barclay A. Phillips
SVP, Chief Financial Officer and Treasurer
Andrea N. Flynn, Ph.D.
Senior Manager, Investor Relations
ir@novavax.com
240-268-2000
Russo Partners, LLC
David Schull
Todd Davenport, Ph.D.
david.schull@russopartnersllc.com
todd.davenport@russopartnersllc.com
212-845-4271
Novavax (NASDAQ:NVAX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Novavax (NASDAQ:NVAX)
Historical Stock Chart
From Apr 2023 to Apr 2024